NCT05284214 2023-09-15
SALIENT
Partner Therapeutics, Inc.
Phase 2 Withdrawn
Clinical Trials
5 trialsNCT03147976 2019-08-28
QUILT-3.036: AMG 337 in Subjects With Advanced or Metastatic Solid Tumors
NantPharma, LLC
Phase 2 Withdrawn
NCT03166176 2019-05-20
TSC1/2_SC
Samsung Medical Center
Phase 2 Withdrawn
NCT03166904 2019-05-20
RICTOR_SC
Samsung Medical Center
Phase 2 Withdrawn
NCT02656849 2016-07-01
BAY 1000394 for MCL-1-, MYC-, and CCNE1-Amplified Tumors
Dana-Farber Cancer Institute
Phase 2 Withdrawn